• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SiTime Set to Join S&P MidCap 400; Emergent BioSolutions to Join S&P SmallCap 600

    11/22/21 6:01:00 PM ET
    $EBS
    $SITM
    $SPGI
    $UFS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Semiconductors
    Technology
    Get the next $EBS alert in real time by email

    NEW YORK, Nov. 22, 2021 /PRNewswire/ -- SiTime Corp. (NASD: SITM) will replace Emergent BioSolutions Inc. (NYSE:EBS) in the S&P MidCap 400, and Emergent BioSolutions will replace Domtar Corp. (NYSE:UFS) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, November 30. Paper Excellence B.V. is acquiring Domtar in a deal expected to be completed soon pending final conditions. Emergent BioSolutions is more representative of the small-cap market space.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    Nov 30, 2021

    S&P MidCap 400

    Addition

    SiTime

    SITM

    Information Technology



    S&P MidCap 400

    Deletion

    Emergent BioSolutions

    EBS

    Health Care



    S&P SmallCap 600

    Addition

    Emergent BioSolutions

    EBS

    Health Care



    S&P SmallCap 600

    Deletion

    Domtar

    UFS

    Materials

    For more information about S&P Dow Jones Indices, please visit www.spdji.com

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected]

    Media Inquiries

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/sitime-set-to-join-sp-midcap-400-emergent-biosolutions-to-join-sp-smallcap-600-301430362.html

    SOURCE S&P Dow Jones Indices

    Get the next $EBS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EBS
    $SITM
    $SPGI
    $UFS

    CompanyDatePrice TargetRatingAnalyst
    SiTime Corporation
    $SITM
    1/15/2026Underweight → Equal Weight
    Barclays
    SiTime Corporation
    $SITM
    12/15/2025$420.00Buy
    Goldman
    SiTime Corporation
    $SITM
    11/21/2025$350.00Buy
    Loop Capital
    S&P Global Inc.
    $SPGI
    10/1/2025$540.00Buy
    Seaport Research Partners
    SiTime Corporation
    $SITM
    8/14/2025$260.00Buy
    UBS
    S&P Global Inc.
    $SPGI
    4/10/2025$600.00Buy
    BofA Securities
    S&P Global Inc.
    $SPGI
    3/12/2025$599.00Outperform
    Mizuho
    Emergent BioSolutions Inc.
    $EBS
    12/30/2024$15.00Buy
    H.C. Wainwright
    More analyst ratings

    $EBS
    $SITM
    $SPGI
    $UFS
    SEC Filings

    View All

    SEC Form S-8 filed by SiTime Corporation

    S-8 - SITIME Corp (0001451809) (Filer)

    2/11/26 4:25:53 PM ET
    $SITM
    Semiconductors
    Technology

    SEC Form 10-K filed by SiTime Corporation

    10-K - SITIME Corp (0001451809) (Filer)

    2/11/26 4:06:57 PM ET
    $SITM
    Semiconductors
    Technology

    S&P Global Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - S&P Global Inc. (0000064040) (Filer)

    2/10/26 7:10:08 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $EBS
    $SITM
    $SPGI
    $UFS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, S&P Global Mobility Eager William W bought $11,917 worth of shares (23 units at $517.58), increasing direct ownership by 0.26% to 8,724 units (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    1/15/26 4:01:18 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    President and CEO Papa Joseph C bought $349,800 worth of shares (60,000 units at $5.83), increasing direct ownership by 21% to 342,500 units (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    5/15/25 4:02:40 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Jacoby Rebecca bought $8,971 worth of shares (69 units at $130.01), increasing direct ownership by 17% to 469 units (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    6/17/24 4:04:40 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $EBS
    $SITM
    $SPGI
    $UFS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $EBS
    $SITM
    $SPGI
    $UFS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $EBS
    $SITM
    $SPGI
    $UFS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, February 26, 2026, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year of 2025. Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent's website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of

    2/12/26 9:02:20 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CARFAX: 225,000 More Vehicles Receive "Do Not Drive" Warning for Takata Airbags

    Fiat Chrysler Automobiles Issues Urgent Warning for Vehicles with Unfixed Takata Airbags CENTREVILLE, Va., Feb. 11, 2026 /PRNewswire/ -- Fiat Chrysler Automobiles (FCA) has issued a sweeping "Do Not Drive" warning for all of its vehicles with an unrepaired Takata airbag recall, adding around 225,000 vehicles on U.S. roads that are considered to be potentially life-threatening. This alert underscores the urgency for owners to check their recall status immediately.CARFAX data shows more than 5 million vehicles nationwide still carry defective Takata airbags more than a decade after NHTSA launched the nationwide recall.Here are the Top 10 States with the Most Unrepaired Takata Airbags: Before

    2/11/26 7:37:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    S&P Global Reports Fourth Quarter and Full-Year 2025 Results

    NEW YORK, Feb. 10, 2026 /PRNewswire/ -- S&P Global (NYSE:SPGI) today reported fourth quarter and full-year 2025 results. The Company's earnings release and supplemental materials are available at http://investor.spglobal.com/Quarterly-Earnings.  Supplemental Information/Conference Call/Webcast Details:  The Company's senior management will review the fourth quarter and full-year 2025 earnings results on a conference call scheduled for today, February 10, at 8:30 a.m. ET. Additional information presented on the conference call, and the Company's supplemental slide content may b

    2/10/26 7:22:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    SiTime upgraded by Barclays

    Barclays upgraded SiTime from Underweight to Equal Weight

    1/15/26 8:30:58 AM ET
    $SITM
    Semiconductors
    Technology

    Goldman initiated coverage on SiTime with a new price target

    Goldman initiated coverage of SiTime with a rating of Buy and set a new price target of $420.00

    12/15/25 10:01:13 AM ET
    $SITM
    Semiconductors
    Technology

    Loop Capital initiated coverage on SiTime with a new price target

    Loop Capital initiated coverage of SiTime with a rating of Buy and set a new price target of $350.00

    11/21/25 8:11:45 AM ET
    $SITM
    Semiconductors
    Technology

    SVP, General Counsel, Corp Sec Perl Jessica covered exercise/tax liability with 918 shares, decreasing direct ownership by 1% to 67,469 units (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    2/10/26 7:11:20 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, Quality & Ethics, and CPL Glessner Coleen returned $315,009 worth of shares to the company (28,847 units at $10.92) and covered exercise/tax liability with 2,852 shares, decreasing direct ownership by 22% to 112,620 units (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    2/10/26 7:09:25 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SVP, Products Business Williams Paul Anthony returned $94,513 worth of shares to the company (8,655 units at $10.92) and covered exercise/tax liability with 1,022 shares, decreasing direct ownership by 11% to 76,194 units (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    2/10/26 7:07:24 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EBS
    $SITM
    $SPGI
    $UFS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Emergent BioSolutions Inc.

    SC 13G - Emergent BioSolutions Inc. (0001367644) (Subject)

    11/13/24 4:00:18 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by SiTime Corporation

    SC 13G/A - SITIME Corp (0001451809) (Subject)

    11/12/24 10:34:18 AM ET
    $SITM
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by Emergent BioSolutions Inc.

    SC 13G/A - Emergent BioSolutions Inc. (0001367644) (Subject)

    11/8/24 5:23:28 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EBS
    $SITM
    $SPGI
    $UFS
    Leadership Updates

    Live Leadership Updates

    View All

    RingCentral Set to Join S&P SmallCap 600

    NEW YORK, Feb. 9, 2026 /PRNewswire/ -- RingCentral Inc. (NYSE:RNG) will replace Hillenbrand Inc. (NYSE:HI) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, February 12. Lone Star Funds is acquiring Hillenbrand in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Feb 12, 2026 S&P SmallCap 600 Addition RingCentral RNG Information Technology Feb 12, 2026 S&P SmallCap 600 Deletion Hillenbrand HI Industrials ABOUT S&P DOW JONES INDICES S&P Dow Jones Indices is the large

    2/9/26 6:08:00 PM ET
    $HI
    $RNG
    $SPGI
    Miscellaneous manufacturing industries
    Consumer Discretionary
    EDP Services
    Technology

    Merchants Bancorp Set to Join S&P SmallCap 600

    NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Merchants Bancorp (NASD: MBIN) will replace TreeHouse Foods Inc. (NYSE:THS) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 11. Investindustrial S.A. and its affiliates are acquiring Treehouse Foods in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Feb 11, 2026 S&P SmallCap 600 Addition Merchants Bancorp MBIN Financial Feb 11, 2026 S&P SmallCap 600 Deletion TreeHouse Foods THS Consumer Staples ABOUT S&P DOW

    2/6/26 6:24:00 PM ET
    $MBIN
    $SPGI
    $THS
    Major Banks
    Finance
    Finance: Consumer Services
    Packaged Foods

    Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600

    NEW YORK, Feb. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600:  S&P MidCap 400 constituent Ciena Corp. (NYSE:CIEN) will replace Dayforce Inc. (NYSE:DAY) in the S&P 500, S&P SmallCap 600 constituent Arrowhead Pharmaceuticals Inc. (NASD: ARWR) will replace Ciena in the S&P MidCap 400, and ADT Inc. (NYSE:ADT) will replace Arrowhead Pharmaceuticals in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 9. Thoma Bravo L.P. acquired Dayforce in a deal that closed today.OneSpaWorld Holdings Ltd. (NASD: OSW) will replace Dynavax Technologies Corp. (NASD: DVAX) in the S&P SmallCap 600 effec

    2/4/26 6:15:00 PM ET
    $ADT
    $ARWR
    $CIEN
    Diversified Commercial Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EBS
    $SITM
    $SPGI
    $UFS
    Financials

    Live finance-specific insights

    View All

    Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, February 26, 2026, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year of 2025. Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent's website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of

    2/12/26 9:02:20 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    S&P Global Reports Fourth Quarter and Full-Year 2025 Results

    NEW YORK, Feb. 10, 2026 /PRNewswire/ -- S&P Global (NYSE:SPGI) today reported fourth quarter and full-year 2025 results. The Company's earnings release and supplemental materials are available at http://investor.spglobal.com/Quarterly-Earnings.  Supplemental Information/Conference Call/Webcast Details:  The Company's senior management will review the fourth quarter and full-year 2025 earnings results on a conference call scheduled for today, February 10, at 8:30 a.m. ET. Additional information presented on the conference call, and the Company's supplemental slide content may b

    2/10/26 7:22:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    SiTime to Acquire Renesas' Timing Business

    Acquired Business Expected to Generate $300 Million in Revenue in 12 Months Post-Close, with 70% Gross MarginHigh-Growth AI Datacenter-Comms Represents ~75% of Acquired Revenue Accelerates SiTime's Path to $1 Billion of Revenue as the Premier Pure-Play Precision Timing Company Signed Partnership MOU to Explore SiTime's MEMS Resonator Integration in Renesas' Embedded ComputingSiTime Conference Call Today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) SANTA CLARA, Calif. and TOKYO, Feb. 04, 2026 (GLOBE NEWSWIRE) -- SiTime Corporation (NASDAQ:SITM) ("SiTime" or the "Company"), the Precision Timing company, and Renesas Electronics Corporation (TSE: 6723) ("Renesas"), a premier supplier of

    2/4/26 4:10:00 PM ET
    $SITM
    Semiconductors
    Technology